Back to Results

Clover Health Investments Corp (CLOV)

Featured in High-Beta Momentum Bullish Trend Stocks

Clover Health Investments Corp is a healthcare company listed on NASDAQ as common stock under the ticker CLOV. The company focuses on Medicare Advantage plans for Medicare-eligible individuals in the United States, including preferred provider organization and health maintenance organization plans. Alongside its insurance business, Clover Health operates Clover Assistant, a software platform designed to help physicians detect, identify, and manage chronic diseases. Founded in 2014, the company is based in Wilmington, Delaware.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
NASDAQ-CLOV
$4.20
-5.8% Downside
Fair
$5.38
20.7% Upside
Undervalued
Great
0.0%
November 9, 2026
6.3x
1.0x
2.369 B
1.964 B
0.0%
77.7%
3.5
-404.1%
Valuation • Fair Value

Clover Health Investments Corp (NASDAQ-CLOV) Fair Value by Valuation Model

Review the available estimates for Clover Health Investments Corp (NASDAQ-CLOV), including Comps Fair Value.

Primary Valuation Read

Fair Value

$4.20

Estimated downside of 5.8% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

Comps Fair Value

$4.20

Comparable-company valuation reference.

Analyst Price Target

$5.38

Analysts imply upside of 20.7%.

How to read these valuation models

Use the 4 available valuation references for Clover Health Investments Corp (NASDAQ-CLOV) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Clover Health Investments Corp (NASDAQ-CLOV)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

2.476 B

Current operating scale indicator.

Revenue Forecast

2.957 B

Forward revenue estimate.

EBITDA

-17.956 M

Current operating profitability reference.

EBITDA Forecast

79.083 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Clover Health Investments Corp (NASDAQ-CLOV) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Clover Health Investments Corp (NASDAQ-CLOV)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Great

Positive financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.54

No elevated caution signal from this screen.

Altman Z-Score

3.5

Relatively strong balance-sheet zone.

FCF / Net Income

-404.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Clover Health Investments Corp (NASDAQ-CLOV). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Clover Health Investments Corp (NASDAQ-CLOV)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 9, 2026

Days to Earnings

52

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Clover Health Investments Corp (NASDAQ-CLOV), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Clover Health Investments Corp (NASDAQ-CLOV) Stock Forecast & Technical Outlook

Review Clover Health Investments Corp (NASDAQ-CLOV) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Clover Health Investments Corp (NASDAQ-CLOV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Clover Health Investments Corp (NASDAQ-CLOV) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Clover Health Investments Corp (NASDAQ-CLOV) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Buy

The weekly technical read for Clover Health Investments Corp (NASDAQ-CLOV) is currently Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Clover Health Investments Corp (NASDAQ-CLOV) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Clover Health Investments Corp (NASDAQ-CLOV)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Clover Health Investments Corp (NASDAQ-CLOV) has a Buy consensus, with 2 buy, 2 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 2
Sell 0
FAQ • Fast Investor Answers

Clover Health Investments Corp (NASDAQ-CLOV) Stock FAQ

Data-supported answers about Clover Health Investments Corp (NASDAQ-CLOV), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$4.20
Estimated downside 5.8%
Valuation Rating
Overvalued
Estimated downside of 5.8%
Analyst Target
$5.38
Implied upside 20.7%
Financial Health
Great
Current financial-health read

The current fair value estimate for Clover Health Investments Corp (NASDAQ-CLOV) is $4.20. This implies an estimated downside of 5.8% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 5.8% versus the current market price.

The available analyst price target for Clover Health Investments Corp (NASDAQ-CLOV) is $5.38. The analyst target implies estimated upside of 20.7%.

The current financial health read for Clover Health Investments Corp (NASDAQ-CLOV) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Clover Health Investments Corp (NASDAQ-CLOV) is November 9, 2026.

The latest available data indicates no current dividend yield for Clover Health Investments Corp (NASDAQ-CLOV).

The current market capitalization listed for Clover Health Investments Corp is 2.369 B.

The current enterprise value listed for Clover Health Investments Corp is 1.964 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Clover Health Investments Corp is NASDAQ-CLOV, and the stock is listed on NASDAQ.

Clover Health Investments Corp (NASDAQ-CLOV) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Clover Health Investments Corp is 0.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Clover Health Investments Corp is 77.7%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on NASDAQ

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Fair Market Cap 338.3 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 113.6 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 102 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 92.6 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 89.122 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.74 B
COR NYSE Cencora Inc Fair Value Undervalued Market Cap 58.924 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 52.418 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 46.377 B
CNC NYSE Centene Corp Fair Value Fair Market Cap 32.164 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 27.202 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 26.01 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 24.072 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.095 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.011 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.838 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.778 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.725 B
MOH NYSE Molina Healthcare Inc Fair Value Undervalued Market Cap 10.459 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.413 B